There may be changes to a study due to COVID-19 restrictions. Please reach out to the study coordinators at 202-476-6067 with specific questions.
Psychiatry Clinical Trials at Children’s National Hospital are conducted by Adelaide Robb, M.D. Dr. Robb has been participating in pediatric clinical trials since 1999. These studies include treatments for a variety of mental health conditions affecting kids and teens, such as depression, ADHD, schizophrenia and bipolar disorder.
Currently Enrolling Clinical Trials
NCT05303064
OLZ/SAM vs Olanzapine to Evaluate Weight Gain in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
This is a Phase 3, randomized, double-blind, 52-Week study of OLZ/SAM vs Olanzapine to evaluate weight gain as assessed by change in BMI Z-Score in pediatric subjects with schizophrenia or bipolar I disorder (ENLIGHTEN-Youth).
- Investigator: Adelaide Robb, M.D.
- Sponsor: Alkermes, Inc.
Full study details on ClinicalTrials.gov.
Interested in participating?
If you are interested in having your child participate in psychiatry research now or in the future please provide your contact information. One of our study coordinators will reach out to you with more information.
NCT05081245
ML-004 to Evaluate Social Communication Deficits in Adolescents with Autism Spectrum Disorders (ASD)
This is a randomized, double-blind, parallel group, placebo-controlled study to investigate the efficacy, safety and tolerability of ML-004 on the improvement of social communication deficits in adolescents with ASD.
- Investigator: Adelaide Robb, M.D.
- Sponsor: MapLight Therapeutics
Full study details on ClinicalTrials.gov.